accountSunday at the European Society of Cardiology in Barcelona. The drug competes with German pharmaceutical and chemical company Bayer AG's ( BAY.XE) Xarelto. Both are approved in the U.S. and Europe for preventing clots after hip and knee replacements....
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Boehringer's Pradaxa Shows Good Stroke Reduction In Trial
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account